Health technology innovations that would save the NHS money in both the short and longer term are facing significant challenges in being adopted says a new research commissioned by Medilink partner Nabarro.
According to the report, the NHS could harness the potential of technological innovation to fulfil one of its key objectives from the 2014 NHS Five Year Forward View: promising to deliver better patient care at a lower cost.
Forte Medical’s CEO and Founding Director, Giovanna Forte, explains: “If the NHS is to become a sustainable system that can afford to implement the best innovation for the future, this short-term culture has to change.”
Their product, Peezy Midstream, has the evidence to show that if used across Trusts it would lead to a direct saving to the NHS of £30 million annually. This one example shows the significant importance and cost saving potential of adopting new innovative products.
UK’s ageing population, social care costs and lower net migration mean there are increased demands on the NHS, making cost saving more important now than ever before.
The report shows there is general agreement that procurement practices are too complex, too costly and focused on cost rather than quality of equipment. The survey found that 67% of clinicians believe that procurement practices are disconnected from front-line staff, and 51% of clinicians believed that clinical needs were not taken into account.
Although the full impact of Brexit on the NHS remains to be seen, the report also surmises that Brexit could actually advance the future of the UK health tech industry.
To read the full report, click here.